For medication-induced LCV, withdrawal of the drug is crucial for resolution. A 65-year-old man developed purpuric palpable lesions of the legs 2 days after receiving his third dose (booster) of Pfizer BioNTech vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Panels A and B).